Inhibition of immune tolerance unmasks drug-induced allergic hepatitis

Hepatology

Volumn 62, Issue 2, 2015, Pages 346-348

  Uetrecht, Jack ^a   Kaplowitz, Neil ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMODIAQUINE; HALOTHANE; INTERLEUKIN 10; CD11B ANTIGEN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; EDITORIAL; ENVIRONMENTAL FACTOR; EOSINOPHILIA; HALOTHANE LIVER INJURY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LIVER FAILURE; LIVER HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SUPPRESSOR CELL; TOXIC HEPATITIS; ANIMAL; BONE MARROW CELL; FEMALE; HEPATITIS; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGENS, CD11B; CD8-POSITIVE T-LYMPHOCYTES; DRUG-INDUCED LIVER INJURY; FEMALE; HALOTHANE; HEPATITIS; MYELOID CELLS;

EID: 84938201479     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27824     Document Type: Editorial

References (11)

1. Vergani D, Mieli-Vergani G, Alberti A, Neuberger J, Eddleston ALWF, Davis M, et al. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 1980;303:66-71.
2. Satoh H, Martin BM, Schulick AH, Christ DD, Kenna JG, Pohl LR. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc Natl Acad Sci USA 1989;86:322-326.
3. Ng W, Lobach AR, Zhu X, Chen X, Liu F, Sharma AM, et al. Animal models of idiosyncratic drug reactions. Adv Pharmacol 2012;63:81-135.
4. Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 2010;42:711-714.
5. Chakraborty M, Fullerton AM, Semple K, Chea LS, Proctor WR, Bourdi M, et al. Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment. Hepatology 2015;62:546-557.
6. Kaplowitz N, Deleve LD. Drug-Induced Liver Disease, 3rd ed. New York: Elsevier; 2013.
7. Metushi IG, Hayes MA, Uetrecht J. Treatment of PD-1 mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients. Hepatology 2015;61:1332-1342.
8. Bourdi M, Chen W, Peter RM, Martin JL, Buters JT, Nelson SD, et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 1996;9:1159-1166.
9. Metushi IG, Sanders C, Lee WM, Uetrecht J; Acute Liver Study Group. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure. Hepatology 2014;59:1084-1093.
10. Pachkoria K, Lucena MI, Crespo E, Ruiz-Cabello F, Lopez-Ortega S, Fernandez MA, et al. Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome. J Hepatol 2008;49:107-114.
11. Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009;41:816-819.